Skip to content

IMichon/Dextromethorphan-Model

 
 

Folders and files

NameName
Last commit message
Last commit date

Latest commit

 

History

64 Commits
 
 
 
 
 
 
 
 
 
 

Repository files navigation

Dextromethorphan-Model

Physiologically-Based Pharmacokinetic (PBPK) Modeling of Dextromethorphan and its metabolites (dextrorphan and dextrorphan O-glucuronide) in adults with different CYP2D6 phenotypes.

Repository Files

This repository contains:

  • a PK-Sim snapshot (*.json) file of the current whole-body PBPK model of dextromethorphan, dextrorphan and dextrorphan O-glucuronide
  • static content (e.g. text blocks, *.md files) as inputs for an evaluation plan
  • an evaluation plan (evaluation_plan.json) to create an evaluation report using the snapshot and static text blocks to display the performance of the model

The current model of dextromethorphan and its metabolites is based on the model developed by Rüdesheim et al 2022, for further details, please refer to [1]. The whole-body PBPK model of dextromethorphan and its metabolites dextrorphan and dextrorphan O-glucuronide has been developed and evaluated for the prediction of dextromethorphan, dextrorphan and dextrorphan O-glucuronide plasma concentrations after intravenous and oral administration over a wide dose range (5 to 80 mg). The PBPK model was developed to describe the effect of genetic variants in the CYP2D6 gene on the pharmacokinetics of dextromethorphan. For this purpose, CYP2D6 kcat values were optimized for different CYP2D6 activity scores.

Code of conduct

Everyone interacting in the Open Systems Pharmacology community (codebases, issue trackers, chat rooms, mailing lists etc...) is expected to follow the Open Systems Pharmacology code of conduct.

Contribution

We encourage contribution to the Open Systems Pharmacology community. Before getting started please read the contribution guidelines. If you are contributing code, please be familiar with the coding standard.

License

The model code is distributed under the GPLv2 License.

Reference

[1] Rüdesheim S, Selzer D, Fuhr U, Schwab M, Lehr T. Physiologically-based pharmacokinetic modeling of dextromethorphan to investigate interindividual variability within CYP2D6 activity score groups. CPT Pharmacometrics Syst Pharmacol. 2022;00:1-18. https://onlinelibrary.wiley.com/doi/10.1002/psp4.12776

About

PBPK Model of Dextromethorphan and its Metabolites V11.2

Resources

Stars

Watchers

Forks

Releases

No releases published

Packages

 
 
 

Contributors

Languages

  • R 100.0%